Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (63)

1

B-cell depletion in the therapy of multiple sclerosis : ofatumumab is a new player

enthalten in: Ideggyogyaszati szemle | 2022

von Pukoli, D. | Vécsei, L.

2

Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature

enthalten in: Magyar onkologia | 2018

von Szegedi, I. | Gáspár, I. | Gyurina, K. | +2

3

The labyrinth of residual risk : reduction of the remaining lipid and inflammation risk in the prevention of atherosclerosis

enthalten in: Orvosi hetilap | 2018

von Márk, L. | Harangi, M. | Paragh, G.

4

Advances in immunotherapy for metastatic melanoma

enthalten in: Magyar onkologia | 2017

von Oláh, J.

5

Immunotherapy for lung cancer

enthalten in: Magyar onkologia | 2017

von Ostoros, G.

6

Ramucirumab - a new anticancer agent

enthalten in: Orvosi hetilap | 2016

von Telekes, A. | Deme, D.

7

Biological therapy in idiopathic inflammatory myopathies

enthalten in: Orvosi hetilap | 2014

von Bodoki, L. | Nagy-Vincze, M. | Griger, Z. | +3

8

Monoclonal antibody therapy in breast cancer

enthalten in: Magyar onkologia | 2013

von Dank, M. | Tõkés, T.

9

Epidemiology, predictors and clinical aspects of loss of response to biological therapy

enthalten in: Orvosi hetilap | 2012

von Lorinczy, K. | Miheller, P. | Kiss, S. | +1

10

Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary

enthalten in: Orvosi hetilap | 2011

von Kiss, L. | Szamosi, T. | Molnár, T. | +21

1
2
3
4
5
6
7
Nächster »
[7]